A generic insomnia drug, Zolpidem Sublingual tablets has been launche by the drug major Lupin in the US market with 180 days of marketing exclusivity....
EquityPanditβs Outlook for Lupin for the week (AprilΒ 04, 2016 β AprilΒ 08, 2016): LUPIN: Lupin closed the week on negative note losing around 3.90%....
Lupin said that it has concluded the acquisition of privately held US-based GAVIS Pharmaceuticals LLC and Novel Laboratories (GAVIS). The acquisition was announced by Lupin...